Royal Bank of Canada’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.6M | Buy |
60,703
+15,452
| +34% | +$3.39M | ﹤0.01% | 1782 |
|
|
2026
Q1 | $8.56M | Buy |
45,251
+6,695
| +17% | +$1.17M | ﹤0.01% | 2022 |
|
|
2025
Q4 | $6.55M | Sell |
38,556
-141,143
| -79% | -$21.6M | ﹤0.01% | 2230 |
|
|
2025
Q3 | $23.7M | Buy |
179,699
+103,583
| +136% | +$12.4M | ﹤0.01% | 1512 |
|
|
2025
Q2 | $8.08M | Buy |
76,116
+8,502
| +13% | +$924K | ﹤0.01% | 2188 |
|
|
2025
Q1 | $8.39M | Buy |
67,614
+33,210
| +97% | +$4.33M | ﹤0.01% | 1877 |
|
|
2024
Q4 | $4.24M | Buy |
34,404
+3,868
| +13% | +$456K | ﹤0.01% | 2445 |
|
|
2024
Q3 | $3.4M | Sell |
30,536
-375
| -1% | -$41.1K | ﹤0.01% | 2591 |
|
|
2024
Q2 | $3.3M | Sell |
30,911
-5,395
| -15% | -$593K | ﹤0.01% | 2515 |
|
|
2024
Q1 | $4.37M | Buy |
36,306
+145
| +0.4% | +$17.8K | ﹤0.01% | 2286 |
|
|
2023
Q4 | $4.45M | Sell |
36,161
-86,359
| -70% | -$10.8M | ﹤0.01% | 2352 |
|
|
2023
Q3 | $15.9M | Buy |
122,520
+54,771
| +81% | +$7.3M | ﹤0.01% | 1293 |
|
|
2023
Q2 | $8.4M | Sell |
67,749
-51,894
| -43% | -$6.98M | ﹤0.01% | 1712 |
|
|
2023
Q1 | $17.5M | Buy |
119,643
+13,259
| +12% | +$1.96M | ﹤0.01% | 1219 |
|
|
2022
Q4 | $16.9M | Buy |
106,384
+15,240
| +17% | +$2.23M | ﹤0.01% | 1252 |
|
|
2022
Q3 | $12.1M | Sell |
91,144
-27,767
| -23% | -$4.22M | ﹤0.01% | 1394 |
|
|
2022
Q2 | $18.6M | Buy |
118,911
+30,878
| +35% | +$4.75M | 0.01% | 1143 |
|
|
2022
Q1 | $13.7M | Buy |
88,033
+27,558
| +46% | +$4M | ﹤0.01% | 1497 |
|
|
2021
Q4 | $7.7M | Sell |
60,475
-36,265
| -37% | -$4.77M | ﹤0.01% | 2074 |
|
|
2021
Q3 | $12.6M | Sell |
96,740
-35,566
| -27% | -$5.37M | ﹤0.01% | 1663 |
|
|
2021
Q2 | $23.5M | Buy |
132,306
+64,648
| +96% | +$11.2M | 0.01% | 1220 |
|
|
2021
Q1 | $11.1M | Sell |
67,658
-80,045
| -54% | -$13.2M | ﹤0.01% | 1680 |
|
|
2020
Q4 | $24.4M | Sell |
147,703
-2,656
| -2% | -$396K | 0.01% | 1119 |
|
|
2020
Q3 | $21.4M | Sell |
150,359
-18,215
| -11% | -$2.26M | 0.01% | 1035 |
|
|
2020
Q2 | $18.6M | Sell |
168,574
-1,820
| -1% | -$201K | 0.01% | 1079 |
|
|
2020
Q1 | $17M | Buy |
170,394
+6,594
| +4% | +$853K | 0.01% | 1000 |
|
|
2019
Q4 | $24.5M | Sell |
163,800
-16,021
| -9% | -$2.18M | 0.01% | 1025 |
|
|
2019
Q3 | $23M | Buy |
179,821
+5,091
| +3% | +$682K | 0.01% | 993 |
|
|
2019
Q2 | $24.9M | Buy |
174,730
+8,247
| +5% | +$1.11M | 0.01% | 944 |
|
|
2019
Q1 | $23.8M | Sell |
166,483
-3,463
| -2% | -$452K | 0.01% | 957 |
|
|
2018
Q4 | $21.1M | Sell |
169,946
-22,489
| -12% | -$3.34M | 0.01% | 959 |
|
|
2018
Q3 | $32.3M | Sell |
192,435
-22,551
| -10% | -$3.88M | 0.01% | 837 |
|
|
2018
Q2 | $37M | Buy |
214,986
+39,767
| +23% | +$6.5M | 0.02% | 709 |
|
|
2018
Q1 | $26.5M | Sell |
175,219
-51,445
| -23% | -$7.55M | 0.01% | 907 |
|
|
2017
Q4 | $30.5M | Sell |
226,664
-96,397
| -30% | -$13.4M | 0.01% | 871 |
|
|
2017
Q3 | $47.2M | Sell |
323,061
-32,340
| -9% | -$4.89M | 0.02% | 588 |
|
|
2017
Q2 | $55.3M | Sell |
355,401
-41,318
| -10% | -$6.32M | 0.03% | 496 |
|
|
2017
Q1 | $57.6M | Sell |
396,719
-237,998
| -37% | -$31M | 0.03% | 450 |
|
|
2016
Q4 | $69.2M | Buy |
634,717
+305,863
| +93% | +$34.1M | 0.04% | 392 |
|
|
2016
Q3 | $39.9M | Buy |
328,854
+162,395
| +98% | +$21.9M | 0.02% | 600 |
|
|
2016
Q2 | $23.5M | Buy |
166,459
+92,318
| +125% | +$13.6M | 0.01% | 852 |
|
|
2016
Q1 | $9.68M | Buy |
74,141
+52,088
| +236% | +$6.48M | 0.01% | 1400 |
|
|
2015
Q4 | $3.1M | Buy |
22,053
+2,665
| +14% | +$369K | ﹤0.01% | 2194 |
|
|
2015
Q3 | $2.57M | Buy |
19,388
+3,842
| +25% | +$662K | ﹤0.01% | 2047 |
|
|
2015
Q2 | $2.74M | Buy |
15,546
+1,872
| +14% | +$336K | ﹤0.01% | 2074 |
|
|
2015
Q1 | $2.36M | Sell |
13,674
-3,936
| -22% | -$676K | ﹤0.01% | 2146 |
|
|
2014
Q4 | $2.88M | Buy |
17,610
+7,076
| +67% | +$1.17M | ﹤0.01% | 2051 |
|
|
2014
Q3 | $1.69M | Sell |
10,534
-1,887
| -15% | -$290K | ﹤0.01% | 2447 |
|
|
2014
Q2 | $1.83M | Buy |
12,421
+3,777
| +44% | +$524K | ﹤0.01% | 2361 |
|
|
2014
Q1 | $1.2M | Sell |
8,644
-19,924
| -70% | -$3M | ﹤0.01% | 2628 |
|
|
2013
Q4 | $3.62M | Buy |
28,568
+26,099
| +1,057% | +$2.7M | ﹤0.01% | 1870 |
|
|
2013
Q3 | $227K | Sell |
2,469
-3,000
| -55% | -$242K | ﹤0.01% | 4000 |
|
|
2013
Q2 | $376K | Buy |
+5,469
| New | +$334K | ﹤0.01% | 3399 |
|
Other funds holding JAZZ
Royal Bank of Canada's JAZZ Position: Q2 2026 in Review
Royal Bank of Canada increased its Jazz Pharmaceuticals (JAZZ) stake by 34% in Q2 2026, buying an estimated $3.39M and bringing the position to 60,703 shares worth $14.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1782.
Royal Bank of Canada first reported a position in JAZZ in Q2 2013 and has held it in 53 quarters since. The position peaked at $69.2M in Q4 2016. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Royal Bank of Canada held 60,703 shares of Jazz Pharmaceuticals worth $14.6M as of Q2 2026.
- Royal Bank of Canada bought 15,452 Jazz Pharmaceuticals shares in Q2 2026, an estimated $3.39M.
- Jazz Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #1782 holding.
- Royal Bank of Canada first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Royal Bank of Canada's Jazz Pharmaceuticals position peaked at $69.2M in Q4 2016.
- 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.